Northwest Biotherapeutics: 3Q Earnings Snapshot

BETHESDA, Md. (AP) _ Northwest Biotherapeutics Inc. (NWBO) on Friday reported a loss of $194.1 million in its third quarter.

The Bethesda, Maryland-based company said it had a loss of 26 cents per share. Losses, adjusted for non-recurring costs and to extinguish debt, were 7 cents per share.

The cancer drug developer posted revenue of $216,000 in the period.

The company’s shares closed at $1.32. A year ago, they were trading at 21 cents.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NWBO at

Copyright © 2021 . All rights reserved. This website is not intended for users located within the European Economic Area.


Sign up for breaking news alerts